title: Interactive effect of inhaled bradykinin with histamine and PGD2 in bronchial asthma.
abstract: Interaction among mediators such as bradykinin (BK), histamine (H), and prostaglandin (PG) D2 may contribute to reduction in airway caliber in asthma. Ten stable asthmatic subjects took part in a study to investigate possible mediator interaction. The provocative concentration of mediator required to reduce forced expiratory volume in 1 s (FEV1) by 12.5% from the starting baseline value (PC12.5) and that required to reduce the fall in FEV1 from 12.5 to 25% (PC25-12.5) of H, BK, and PGD2 were determined. On three subsequent occasions, subjects inhaled either the vehicle plus BK PC12.5 or the vehicle plus H or PGD2 PC25-12.5, and FEV1 was measured at regular time intervals up to 40 min. Predicted time course curves were calculated from these results. On two additional occasions, interactive time course studies were undertaken when the subject inhaled BK PC12.5 followed by H or PGD2 PC25-12.5. On a further three visits, the time courses of individual mediators were studied. When BK was combined with H and PGD2, the maximum fall in FEV1 and the rate of recovery after inhalation of the second mediator were not significantly different from those values of predicted time course responses for the same combination of mediator. Thus, by employing pharmacologically active concentrations of inhaled BK, H, and PGD2, which act through separate receptor mechanisms, we were unable to demonstrate any pharmacological interaction on airway caliber in asthma.
authors.affiliation: Southampton General Hospital, United Kingdom.
authors.forename: K
authors.initials: K
authors.lastname: Rajakulasingam
authors.forename: G
authors.initials: G
authors.lastname: Gnanakumaran
authors.forename: M K
authors.initials: MK
authors.lastname: Church
authors.forename: P H
authors.initials: PH
authors.lastname: Howarth
authors.forename: S T
authors.initials: ST
authors.lastname: Holgate
mesh_terms: D000328:Adult; D000336:Aerosols; D000368:Aged; D001249:Asthma / Q000503:physiopathology*; D001920:Bradykinin / Q000008:administration & dosage / Q000494:pharmacology*; D016535:Bronchial Hyperreactivity; D004305:Dose-Response Relationship, Drug; D005260:Female; D005541:Forced Expiratory Volume; D006632:Histamine / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D008297:Male; D015230:Prostaglandin D2 / Q000008:administration & dosage / Q000494:pharmacology*; D012882:Skin Tests
chemical_list: D000336:Aerosols; D006632:Histamine; D015230:Prostaglandin D2; D001920:Bradykinin